Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Justin J. Bailey, Ralf Schirrmacher, Kristen Farrell & Vadim Bernard-Gauthier. (2017) Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part II. Expert Opinion on Therapeutic Patents 27:7, pages 831-849.
Read now
Read now
Vadim Bernard-Gauthier & Ralf Schirrmacher. (2016) Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition. Expert Opinion on Therapeutic Patents 26:2, pages 291-295.
Read now
Read now
Articles from other publishers (12)
Mohammad Sayed Alam & Dong-Ung Lee. (2023) Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A
(TRKA) Inhibitors: Synthesis, Anticancer Activities, In silico ADME and
Molecular Docking Studies. Medicinal Chemistry 19:1, pages 47-63.
Crossref
Crossref
Shulei Pan, Liting Zhang, Xinling Luo, Jinshan Nan, Wei Yang, Huachao Bin, Yang Li, Qiao Huang, Tianqi Wang, Zhiling Pan, Bo Mu, Falu Wang, Chenyu Tian, Yang Liu, Linli Li & Shengyong Yang. (2022)
Structural Optimization and Structure–Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6
H
-pyrimido[5,4-
b
][1,4]oxazin-7(8
H
)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant Mutants
. Journal of Medicinal Chemistry 65:3, pages 2035-2058.
Crossref
Crossref
Shengyang Cui, Yongjin Wang, Yuting Wang, Xia Tang, Xiaomei Ren, Lei Zhang, Yong Xu, Zhang Zhang, Zhi-Min Zhang, Xiaoyun Lu & Ke Ding. (2019) Design, synthesis and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors. European Journal of Medicinal Chemistry 179, pages 470-482.
Crossref
Crossref
Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. McDonaldFengping Lv, Naresh Gunaganti, Brendan Frett & Hong-yu Li. (2018) Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. Journal of Medicinal Chemistry 62:4, pages 1731-1760.
Crossref
Crossref
Samo Turk, Benjamin Merget, Sameh Eid & Simone Fulle. (2018) From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate. Journal of Medicinal Chemistry 61:11, pages 4851-4859.
Crossref
Crossref
Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher & Peter J. H. Scott. (2017) A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. Journal of Medicinal Chemistry 60:16, pages 6897-6910.
Crossref
Crossref
Bálint Botz, Kata Bölcskei & Zsuzsanna Helyes. (2016) Challenges to develop novel anti‐inflammatory and analgesic drugs. WIREs Nanomedicine and Nanobiotechnology 9:3.
Crossref
Crossref
Bryan H. Norman & Jeff S. McDermott. (2016) Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. Journal of Medicinal Chemistry 60:1, pages 66-88.
Crossref
Crossref
Mohammad Sayed Alam, Sang-Un Choi & Dong-Ung Lee. (2017) Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors. Bioorganic & Medicinal Chemistry 25:1, pages 389-396.
Crossref
Crossref
Jaana Tammiku-Taul, Rahel Park, Kaur Jaanson, Kristi Luberg, Dimitar A. Dobchev, Dzmitry Kananovich, Artur Noole, Merle Mandel, Allen Kaasik, Margus Lopp, Tõnis Timmusk & Mati Karelson. (2016) Indole-like Trk receptor antagonists. European Journal of Medicinal Chemistry 121, pages 541-552.
Crossref
Crossref
Leonid P. Shutov, Charles A. Warwick, Xiaoyu Shi, Aswini Gnanasekaran, Andrew J. Shepherd, Durga P. Mohapatra, Trent M. Woodruff, J. David Clark & Yuriy M. Usachev. (2016) The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1. The Journal of Neuroscience 36:18, pages 5055-5070.
Crossref
Crossref
Vadim Bernard-Gauthier, Justin J. Bailey, Arturo Aliaga, Alexey Kostikov, Pedro Rosa-Neto, Melinda Wuest, Garrett M. Brodeur, Barry J. Bedell, Frank Wuest & Ralf Schirrmacher. (2015)
Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-
b
]pyridazine pan-Trk inhibitors as candidate PET imaging probes
. MedChemComm 6:12, pages 2184-2193.
Crossref
Crossref